Home
Conditions
Lymphoma

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

2,141 public trials 305 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma trial results

Not Yet Recruiting

Study of SP-3164 in Relapsed or Refractory Non-Hodgkin's Lymphoma

NCT05979857

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Navigating the Clinical Research Process for Lymphoma

NCT06070246

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: Power Life Sciences San Francisco, California, United States

View Trial Details

Not Yet Recruiting

Evaluate the Safety, Tolerability, and Pharmacokinetic Characteristics of HLX51 in Patients With Solid Tumor or Lymphoma

NCT05788107

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Lymphoma Patients Undergoing Mediastinal Radiotherapy in the Era of Modern Chemoradiation

NCT03969693

Conditions: Cardiotoxicity, Cardiovascular Diseases, Chemically-Induced Disorders, +19 more
Locations: Chang Gung Memorial Hospital Taoyuan, Taiwan

View Trial Details

Not Yet Recruiting

L-DEP Regimen Combined With PD-1 Antibody as Induction Therapy for Epstein-Barr Virus-positive LA-HLH

NCT05775705

Conditions: DNA Virus Infections, Epstein-Barr Virus, Epstein-Barr Virus Infections, +17 more
Locations: Beijing Friendship Hospital, Capital Medical University Beijing, Beijing Municipality, China

View Trial Details

Not Yet Recruiting

Clinical Study of Improved BEAM Conditioning Regimen for ASCT in Lymphoma

NCT05681403

Conditions: Autologous Hematopoietic Stem Cell Transplantation, Hemic and Lymphatic Diseases, Immune System Diseases, +6 more
Locations: First Affiliated Hospital of Xi'an Jiaotong University Xi'an, Shaanxi, China

View Trial Details

Not Yet Recruiting

Allogeneic T Cells Expressing T Cell Receptor-KDEL and the Chimeric Antigen Receptor CAT19 for the Treatment of Advanced CD19+ Malignancies

NCT05391490

Conditions: Blood Cancer, Hematologic Diseases, Hematologic Neoplasms, +10 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Study to Evaluate the Safety and Tolerance of SYHX1903 in Patients With Relapsed/Refractory Hematologic Malignancies

NCT05055791

Conditions: Acute Myeloid Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +18 more
Locations: Not specified

View Trial Details

Completed

Salvage Treatment With Glofitamab in R/R B-NHL: a GIMEMA-FIL Study

NCT05927558

Conditions: B-cell Non Hodgkin Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +14 more
Locations: Ematologia Istituto Nazionale Tumori Milan, Italy

View Trial Details

Completed

Study to Evaluate the Role of Siltuximab in Treatment of Cytokine Release Syndrome (CRS) and Immune Effector Cell Associated Neurotoxicity (ICANS) Related to CAR-T Cell Therapy

NCT04975555

Conditions: Acute Lymphoblastic Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +26 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

View Trial Details

Lymphoma

Lymphoma trial results

Related conditions